BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 20, Issue 42
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (18888)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.
Item 
Count 
PDF1555
WORD363
HTML13763
Figures (1-2)374
Tables (1-3)289
 Sum=16344
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1225
Download1319
 Sum=2544
Nov 14, 2014 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Paolella G, Mandato C, Pierri L, Poeta M, Di Stasi M, Vajro P. Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(42): 15518-15531 [PMID: 25400436 DOI: 10.3748/wjg.v20.i42.15518]
URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15518.htm
Number Citing Articles
1
Maria Grazia Clemente, Claudia Mandato, Marco Poeta, Pietro Vajro. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. World Journal of Gastroenterology 2016; 22(36): 8078-8093 doi: 10.3748/wjg.v22.i36.8078
2
Tanya Ralli, Zoya Saifi, Neha Tyagi, Arya Vidyadhari, Vidhu Aeri, Kanchan Kohli. Deciphering the role of gut metabolites in non-alcoholic fatty liver disease. Critical Reviews in Microbiology 2023; 49(6): 815 doi: 10.1080/1040841X.2022.2142091
3
Victoria Carroll Cogger, Mashani Mohamad, Samantha Marie Solon-Biet, Alistair M. Senior, Alessandra Warren, Jennifer Nicole O'Reilly, Bui Thanh Tung, Dmitri Svistounov, Aisling Clare McMahon, Robin Fraser, David Raubenheimer, Andrew J. Holmes, Stephen James Simpson, David George Le Couteur. Dietary macronutrients and the aging liver sinusoidal endothelial cell. American Journal of Physiology-Heart and Circulatory Physiology 2016; 310(9): H1064 doi: 10.1152/ajpheart.00949.2015
4
Li-Hao Wu, Mei-Hui Chen, Jie-Yi Cai, Yu Yuan, Li-Quan Wu, Hui-Min Zhou, Lan Li, Kayiu Wan, Xing-Xiang He. The correlation between intestinal mucosal lesions and hepatic dysfunction in patients without chronic liver disease. Medicine 2020; 99(7): e18837 doi: 10.1097/MD.0000000000018837
5
Dengcheng Hui, Lu Liu, Nisma Lena Bahaji Azami, Jingru Song, Yanping Huang, Wan Xu, Chao Wu, Dong Xie, Yulang Jiang, Yanqin Bian, Mingyu Sun. The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial. Frontiers in Endocrinology 2023; 13 doi: 10.3389/fendo.2022.1107071
6
Hyeon-Ji Kim, Hye-Jin Jeon, Dong-Gun Kim, Joo-Yun Kim, Jae-Jung Shim, Jae-Hwan Lee. Lacticaseibacillus paracsei HY7207 Alleviates Hepatic Steatosis, Inflammation, and Liver Fibrosis in Mice with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2024; 25(18): 9870 doi: 10.3390/ijms25189870
7
Marília Marques Pereira Lira, José Eymard Moraes de Medeiros Filho, Vinícius José Baccin Martins, Gitana da Silva, Francisco Antônio de Oliveira Junior, Éder Jackson Bezerra de Almeida Filho, Alexandre Sérgio Silva, João Henrique da Costa-Silva, José Luiz de Brito Alves, Oscar Millet. Association of worsening of nonalcoholic fatty liver disease with cardiometabolic function and intestinal bacterial overgrowth: A cross-sectional study. PLOS ONE 2020; 15(8): e0237360 doi: 10.1371/journal.pone.0237360
8
Samradhi Singh, Mona Kriti, Roberto Catanzaro, Francesco Marotta, Mustafa Malvi, Ajay Jain, Vinod Verma, Ravinder Nagpal, Rajnarayan Tiwari, Manoj Kumar. Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease. Livers 2024; 4(3): 435 doi: 10.3390/livers4030032
9
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathy. Cochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
10
Malwina Mularczyk, Yasmina Bourebaba, Anna Kowalczuk, Krzyzstof Marycz, Lynda Bourebaba. Probiotics-rich emulsion improves insulin signalling in Palmitate/Oleate-challenged human hepatocarcinoma cells through the modulation of Fetuin-A/TLR4-JNK-NF-κB pathway. Biomedicine & Pharmacotherapy 2021; 139: 111560 doi: 10.1016/j.biopha.2021.111560
11
Yan-Lan Fang, Hong Chen, Chun-Lin Wang, Li Liang. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”. World Journal of Gastroenterology 2018; 24(27): 2974-2983 doi: 10.3748/wjg.v24.i27.2974
12
Sanjoy Roychowdhury, Praveen Conjeevaram Selvakumar, Gail A.M. Cresci. The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. Medical Sciences 2018; 6(2): 47 doi: 10.3390/medsci6020047
13
Na Young Lee, Sang Jun Yoon, Dae Hee Han, Haripriya Gupta, Gi Soo Youn, Min Jea Shin, Young Lim Ham, Min Jung Kwak, Byung Yong Kim, Jeong Seok Yu, Do Yup Lee, Tae-Sik Park, Si-Hyun Park, Byoung Kook Kim, Hyun Chae Joung, In Suk Choi, Ji Taek Hong, Dong Joon Kim, Sang Hak Han, Ki Tae Suk. LactobacillusandPediococcusameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. Gut Microbes 2020; 11(4): 882 doi: 10.1080/19490976.2020.1712984
14
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 2022; 94(2): 216 doi: 10.26442/00403660.2022.02.201363
15
Sindhu Mohandas, Vijaya L. Soma, Thi Dong Binh Tran, Erica Sodergren, Tresa Ambooken, David L. Goldman, George Weinstock, Betsy C. Herold. Differences in Gut Microbiome in Hospitalized Immunocompetent vs. Immunocompromised Children, Including Those With Sickle Cell Disease. Frontiers in Pediatrics 2020; 8 doi: 10.3389/fped.2020.583446
16
Nurainina Ayob, Khairul Najmi Muhammad Nawawi, Mohamad Hizami Mohamad Nor, Raja Affendi Raja Ali, Hajar Fauzan Ahmad, Seok Fang Oon, Norfilza Mohd Mokhtar. The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 2023; 11(2): 640 doi: 10.3390/biomedicines11020640
17
Jie Shen, Zhiping Zhang, Ke Chen, Mei Lu, Qiao Qian, Pengfei Liu, Qingyun Gao, Chengfeng Zhang. Prepregnancy obesity status and risks on pregnancy outcomes in Shanghai. Medicine 2018; 97(40): e12670 doi: 10.1097/MD.0000000000012670
18
Sourav Chakraborty, Manthi Dissanayake, Julia Godwin, Xuegeng Wang, Ramji Kumar Bhandari. Ancestral BPA exposure caused defects in the liver of medaka for four generations. Science of The Total Environment 2023; 856: 159067 doi: 10.1016/j.scitotenv.2022.159067
19
Mehreen Siyal, Zaigham Abbas, Muhammad Ali Qadeer, Alina Saeed, Usman Ali, Ambrina Khatoon. Misoprostol for non-alcoholic steatohepatitis: a randomised control trial. BMJ Open Gastroenterology 2024; 11(1): e001342 doi: 10.1136/bmjgast-2023-001342
20
Hui-Ting Chen, Hong-Li Huang, Yong-Qiang Li, Hao-Ming Xu, Yong-Jian Zhou. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. World Journal of Gastroenterology 2020; 26(16): 1901-1911 doi: 10.3748/wjg.v26.i16.1901
21
Menizibeya Osain Welcome. Gastrointestinal Physiology. 2018; : 1009 doi: 10.1007/978-3-319-91056-7_15
22
Nana Zhang, Weiyue Zhang, Xinxin Guo, Jianlin Liu, Shuying Li, Hongtai Zhang, Bei Fan. Genistein protects against hyperglycemia and fatty liver disease in diet-induced prediabetes mice via activating hepatic insulin signaling pathway. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.1072044
23
Junli Xue, Min Zhao, Yunchao Liu, Xiubin Jia, Xiaoyi Zhang, Qianqian Gu, Yunbo Xie, Shucun Qin, Boyan Liu. Hydrogen inhalation ameliorates hepatic inflammation and modulates gut microbiota in rats with high-fat diet-induced non-alcoholic fatty liver disease. European Journal of Pharmacology 2023; 947: 175698 doi: 10.1016/j.ejphar.2023.175698
24
Luis Fontana, Julio Plaza-Díaz, Paula Robles-Bolívar, Héctor Valente-Godínez, María José Sáez-Lara, Francisco Abadía-Molina, Carolina Gómez-Llorente, Ángel Gil, Ana I. Álvarez-Mercado. Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 Modulate Macrophage Gene Expression and Ameliorate Damage Markers in the Liver of Zucker-Leprfa/fa Rats. Nutrients 2021; 13(1): 202 doi: 10.3390/nu13010202
25
Владимир Александрович Карпин, Ольга Ивановна Шувалова. INTESTINAL MICROBIOTA AND LIVER AND KIDNEY DISEASES. Перспективные исследования в психологии, спорте и здравоохранении: сборник статей международной научной конференции (Санкт-Петербург, Май 2024) 2024; : 39 doi: 10.58351/240528.2024.39.50.003
26
Yingchun Wang, Kai Liang, Weizong Kong. Intestinal Trefoil Factor 3 Alleviates the Intestinal Barrier Function Through Reducing the Expression of TLR4 in Rats with Nonalcoholic Steatohepatitis. Archives of Medical Research 2019; 50(1): 2 doi: 10.1016/j.arcmed.2019.03.004
27
Yu Xu, Ning Wang, Hor-Yue Tan, Sha Li, Cheng Zhang, Yibin Feng. Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease. Hepatology International 2021; 15(2): 350 doi: 10.1007/s12072-021-10138-1
28
Hyeonji Kim, Kippeum Lee, Ju-Yeon Kim, Jae-Jung Shim, Junghyun Lim, Joo-Yun Kim, Jung-Lyoul Lee. Lactobacillus helveticus Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse Model. Microorganisms 2023; 11(10): 2466 doi: 10.3390/microorganisms11102466
29
Min-Gyu Jeon, Tae-Rahk Kim, Ji Yeon Lee, Hyun-Su Kim, Yosep Ji, Wilhelm H. Holzapfel, Donghyuck Bae, Chul-yung Choi, Yong Pil Hwang. Hepatoprotective Effects ofStreptococcus thermophilusLM1012 in Mice Exposed to Air Pollutants. Journal of Medicinal Food 2020; 23(8): 852 doi: 10.1089/jmf.2019.4636
30
Yizhe Cui, Qiuju Wang, Renxu Chang, Xiaocui Zhou, Chuang Xu. Intestinal Barrier Function–Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota. Journal of Agricultural and Food Chemistry 2019; 67(10): 2754 doi: 10.1021/acs.jafc.9b00080
31
Sala Horowitz. Therapeutic Modification of the GI Microbiome. Alternative and Complementary Therapies 2015; 21(3): 124 doi: 10.1089/act.2015.29001.sh
32
Marzieh Nemati, Bahareh Ebrahimi, Nima Montazeri-Najafabady. Probiotics ameliorate endocrine disorders via modulating inflammatory pathways: a systematic review. Genes & Nutrition 2024; 19(1) doi: 10.1186/s12263-024-00743-8
33
Jun Zhang, Xiaoqing Geng, Yihui Zhang, Xinlong Zhao, Pengwei Zhang, Guirong Sun, Wenting Li, Donghua Li, Ruili Han, Guoxi Li, Yadong Tian, Xiaojun Liu, Xiangtao Kang, Ruirui Jiang. Interaction Between Cecal Metabolites and Liver Lipid Metabolism Pathways During Induced Molting in Laying Hens. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.862721
34
Rajnish Prakash Singh, Max Kolton, Mayan Boker, Noy Bar David, Stefan Green, Aharon Helman, Oren Tirosh, Zvi Hayouka. Probiotic human alcohol dehydrogenase-4 expressing bacteria protects from diet-induced obesity and metabolic impairment: a new concept of disease prevention. Exploration of Digestive Diseases 2022; : 118 doi: 10.37349/edd.2022.00009
35
Ali A. Mencin, Rohit Loomba, Joel E. Lavine. Caring for children with NAFLD and navigating their care into adulthood. Nature Reviews Gastroenterology & Hepatology 2015; 12(11): 617 doi: 10.1038/nrgastro.2015.146
36
Jelena Popov, Tijana Despot, David Avelar Rodriguez, Irfan Khan, Eugene Mech, Mahrukh Khan, Milan Bojadzija, Nikhil Pai. Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients 2024; 16(11): 1668 doi: 10.3390/nu16111668
37
Aun R. Shah, Sandeep Mukherjee. Impact of gut microbiome on immunotherapy resistance in hepatocellular carcinoma: a review article. Hepatoma Research 2024;  doi: 10.20517/2394-5079.2024.76
38
Sebastião M.B. Duarte, Jose Tadeu Stefano, Claudia P. Oliveira. Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). Annals of Hepatology 2019; 18(3): 416 doi: 10.1016/j.aohep.2019.04.006
39
Anurag S Lavekar, Dhananjay V Raje, Amarja A Lavekar. Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysis. Euroasian Journal of Hepato-Gastroenterology 2017; 7(2): 130 doi: 10.5005/jp-journals-10018-1233
40
Natalia Nuño-Lámbarri, Norberto C. Chávez-Tapia, Misael Uribe. Encyclopedia of Food Chemistry. 2019; : 387 doi: 10.1016/B978-0-08-100596-5.21759-9
41
Sonia Croci, Lina Ilaras D’Apolito, Valeria Gasperi, Maria Valeria Catani, Isabella Savini. Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites. Nutrients 2021; 13(5): 1389 doi: 10.3390/nu13051389
42
Qian Song, Xiang Zhang. The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC. Biomedicines 2022; 10(3): 524 doi: 10.3390/biomedicines10030524
43
Michelle L. Dossett, Ezra M. Cohen, Jonah Cohen. Integrative Medicine for Gastrointestinal Disease. Primary Care: Clinics in Office Practice 2017; 44(2): 265 doi: 10.1016/j.pop.2017.02.002
44
Ruwen Yang, Jingyu Shang, Yaru Zhou, Weiwei Liu, Yaozhou Tian, Hongtao Shang. Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis. Expert Review of Gastroenterology & Hepatology 2021; 15(12): 1401 doi: 10.1080/17474124.2022.2016391
45
Kunli Wang, Bei Li, Rao Fu, Zefang Jiang, Xin Wen, Yuanying Ni. Bentong ginger oleoresin mitigates liver injury and modulates gut microbiota in mouse with nonalcoholic fatty liver disease induced by high‐fat diet. Journal of Food Science 2022; 87(3): 1268 doi: 10.1111/1750-3841.16076
46
Lara Pires, Ana M. González-Paramás, Sandrina A. Heleno, Ricardo C. Calhelha. The Role of Gut Microbiota in the Etiopathogenesis of Multiple Chronic Diseases. Antibiotics 2024; 13(5): 392 doi: 10.3390/antibiotics13050392
47
David R. Seaman. Toxins, Toxicity, and Endotoxemia: A Historical and Clinical Perspective for Chiropractors. Journal of Chiropractic Humanities 2016; 23(1): 68 doi: 10.1016/j.echu.2016.07.003
48
Cathrin Sellmann, Cheng Jun Jin, Christian Degen, Jean-Pascal De Bandt, Ina Bergheim. Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis. The Journal of Nutrition 2015; 145(10): 2280 doi: 10.3945/jn.115.215517
49
Hessah Mohammed Al-muzafar, Kamal Adel Amin. Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers. BMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-016-1540-z
50
Mei Peng, Ya-Li Deng, Ling Yu, Yan-Ting Nie, Ting Luo, Jian Huang, Xi-Hong Zhou, Yiling Ding. Metformin Combined LMWH Intervention in 25 Pregnant Women with History of Hyperlipidemia Pancreatitis in Pregnancy. Global Clinical and Translational Research 2021;  doi: 10.36316/gcatr.03.0043
51
Louis H. S. Lau, Sunny H. Wong. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 111 doi: 10.1007/978-981-10-8684-7_9
52
Zhe Zhang, Xi Liang, Youyou Lv, Huaxi Yi, Yujie Chen, Lu Bai, Hui Zhou, Tongjie Liu, Rui Li, Lanwei Zhang. Evaluation of probiotics for improving and regulation metabolism relevant to type 2 diabetes in vitro. Journal of Functional Foods 2020; 64: 103664 doi: 10.1016/j.jff.2019.103664
53
Emma T. Saltzman, Talia Palacios, Michael Thomsen, Luis Vitetta. Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00061
54
David Avelar-Rodríguez, Rubén Peña-Vélez, Jelena Popov, Lee Hill, Paul MacDaragh Ryan. Probiotics and non-alcoholic fatty liver disease in children and adolescents: a systematic review. Revista Española de Enfermedades Digestivas 2022;  doi: 10.17235/reed.2022.8796/2022
55
Bobae Kim, Jeonghyeon Kwon, Min-Seok Kim, Haryung Park, Yosep Ji, Wilhelm Holzapfel, Chang-Kee Hyun, Marcia B. Aguila. Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice. PLOS ONE 2018; 13(12): e0210120 doi: 10.1371/journal.pone.0210120
56
Lei Cao, Xi-Bing Quan, Wen-Jiao Zeng, Xiao-Ou Yang, Ming-Jie Wang. Mechanism of Hepatocyte Apoptosis. Journal of Cell Death 2016; 9: JCD.S39824 doi: 10.4137/JCD.S39824
57
Nazanin Samadi, Denise Heiden, Martina Klems, Martina Salzmann, Johanna Rohrhofer, Eleonore Weidmann, Larissa Koidl, Erika Jensen-Jarolim, Eva Untersmayr. Gastric Enzyme Supplementation Inhibits Food Allergy in a BALB/c Mouse Model. Nutrients 2021; 13(3): 738 doi: 10.3390/nu13030738
58
Yanbo Wang, Zengbo Wang, Yang Wan, Furong Jin, Xiaodan Shi, Zhishuang Xing, Bo Tian, Bailiang Li. Assessing the in vivo ameliorative effects of Lactobacillus acidophilus KLDS1.0901 for induced non-alcoholic fatty liver disease treatment. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1147423
59
Mingfei Yao, Lingling Qv, Yanmeng Lu, Baohong Wang, Björn Berglund, Lanjuan Li. An Update on the Efficacy and Functionality of Probiotics for the Treatment of Non-Alcoholic Fatty Liver Disease. Engineering 2021; 7(5): 679 doi: 10.1016/j.eng.2020.01.017
60
Fares EM Ali, Mostafa K Abd El-Aziz, Elham I Sharab, Adel G Bakr. Therapeutic interventions of acute and chronic liver disorders: A comprehensive review. World Journal of Hepatology 2023; 15(1): 19-40 doi: 10.4254/wjh.v15.i1.19
61
V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4): 104 doi: 10.22416/1382-4376-2022-32-4-104-140
62
Micaelle Oliveira de Luna Freire, Luciana Caroline Paulino do Nascimento, Kataryne Árabe Rimá de Oliveira, Alisson Macário de Oliveira, Marcos dos Santos Lima, Thiago Henrique Napoleão, João Henrique da Costa Silva, Cláudia Jacques Lagranha, Evandro Leite de Souza, José Luiz de Brito Alves. Limosilactobacillus fermentum Strains with Claimed Probiotic Properties Exert Anti-oxidant and Anti-inflammatory Properties and Prevent Cardiometabolic Disorder in Female Rats Fed a High-Fat Diet. Probiotics and Antimicrobial Proteins 2023; 15(3): 601 doi: 10.1007/s12602-021-09878-1
63
Haiming Hu, Aizhen Lin, Mingwang Kong, Xiaowei Yao, Mingzhu Yin, Hui Xia, Jun Ma, Hongtao Liu. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. Journal of Gastroenterology 2020; 55(2): 142 doi: 10.1007/s00535-019-01649-8
64
Sebastião Mauro Bezerra DUARTE, José Tadeu STEFANO, Denise Siqueira VANNI, Flair José CARRILHO, Claudia Pinto Marques Souza de OLIVEIRA. IMPACT OF CURRENT DIET AT THE RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD). Arquivos de Gastroenterologia 2019; 56(4): 431 doi: 10.1590/s0004-2803.201900000-67
65
Tamiris Ingrid Petito‐da‐Silva, Felipe Missiba Villardi, Aline Penna‐de‐Carvalho, Carlos Alberto Mandarim‐de‐Lacerda, Vanessa Souza‐Mello, Sandra Barbosa‐da‐Silva. An Intestinal FXR Agonist Mitigates Dysbiosis, Intestinal Tight Junctions, and Inflammation in High‐Fat Diet‐Fed Mice. Molecular Nutrition & Food Research 2024; 68(4) doi: 10.1002/mnfr.202300148
66
Stavros Bashiardes, Hagit Shapiro, Shachar Rozin, Oren Shibolet, Eran Elinav. Non-alcoholic fatty liver and the gut microbiota. Molecular Metabolism 2016; 5(9): 782 doi: 10.1016/j.molmet.2016.06.003
67
Aybike Birerdinc, Zobair Younossi. Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?. Journal of Hepatology 2015; 62(4): 761 doi: 10.1016/j.jhep.2015.01.005
68
Junli Ma, Qihang Zhou, Houkai Li. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. Nutrients 2017; 9(10): 1124 doi: 10.3390/nu9101124
69
Yupei Zhang, Kairui Tang, Yuanjun Deng, Runsen Chen, Shu Liang, Huijun Xie, Yifang He, Yanning Chen, Qinhe Yang. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats. Biomedicine & Pharmacotherapy 2018; 102: 1025 doi: 10.1016/j.biopha.2018.03.158
70
Junmeng Yuan, Yu Liu, Fan Zhao, Yuxin Mu, Xinyu Tian, Huawei Liu, Kai Zhang, Jinshan Zhao, Yang Wang. Hepatic Proteomics Analysis Reveals Attenuated Endoplasmic Reticulum Stress in Lactiplantibacillus plantarum-Treated Oxidatively Stressed Broilers. Journal of Agricultural and Food Chemistry 2023; 71(30): 11726 doi: 10.1021/acs.jafc.3c01534
71
Zhongxing Chu, Zuomin Hu, Yi Luo, Yaping Zhou, Feiyan Yang, Feijun Luo. Targeting gut-liver axis by dietary lignans ameliorate obesity: evidences and mechanisms. Critical Reviews in Food Science and Nutrition 2023; : 1 doi: 10.1080/10408398.2023.2272269
72
Daniel Ferraz de Campos Mazo, Rejane Mattar, José Tadeu Stefano, Joyce Matie Kinoshita da Silva-Etto, Márcio Augusto Diniz, Sebastião Mauro Bezerra Duarte, Fabíola Rabelo, Rodrigo Vieira Costa Lima, Priscila Brizolla de Campos, Flair José Carrilho, Claudia P Oliveira. Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitis. World Journal of Hepatology 2016; 8(24): 1019-1027 doi: 10.4254/wjh.v8.i24.1019
73
Mohamed E. Abd El-Hack, Dalia H. Samak, Ahmed E. Noreldin, Karima El-Naggar, Mohamed Abdo. Probiotics and plant-derived compounds as eco-friendly agents to inhibit microbial toxins in poultry feed: a comprehensive review. Environmental Science and Pollution Research 2018; 25(32): 31971 doi: 10.1007/s11356-018-3197-2
74
Jacopo Troisi, Luca Pierri, Annamaria Landolfi, Francesca Marciano, Antonella Bisogno, Federica Belmonte, Carmen Palladino, Salvatore Guercio Nuzio, Pietro Campiglia, Pietro Vajro. Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations. Nutrients 2017; 9(5): 485 doi: 10.3390/nu9050485
75
Claudia Mandato, Angelo Colucci, Roberta Lanzillo, Annamaria Staiano, Elena Scarpato, Luigi Schiavo, Francesca Felicia Operto, Maria Rosaria Serra, Cristina Di Monaco, Julia Sara Napoli, Grazia Massa, Pietro Vajro. Multiple Sclerosis—Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics. Children 2023; 10(6): 1022 doi: 10.3390/children10061022
76
Tingting Yan, Nana Yan, Ping Wang, Yangliu Xia, Haiping Hao, Guangji Wang, Frank J. Gonzalez. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. Acta Pharmaceutica Sinica B 2020; 10(1): 3 doi: 10.1016/j.apsb.2019.11.017
77
Ahmet UYANIKOĞLU. Siroz etiyolojisinde steatohepatitin yeri nedir?. Akademik Gastroenteroloji Dergisi 2019; 19(1): 17 doi: 10.17941/agd.723285
78
莉杰 石. Progress of Intestinal Flora in the Treatment of Autoimmune Liver Disease. Traditional Chinese Medicine 2020; 9(04): 348 doi: 10.12677/TCM.2020.94052
79
Kaiting Ning, Kaikai Lu, Qian Chen, Zizhen Guo, Xiaojuan Du, Farooq Riaz, Lina Feng, Yuping Fu, Chunyan Yin, Fujun Zhang, Litao Wu, Dongmin Li. Epigallocatechin Gallate Protects Mice against Methionine–Choline-Deficient-Diet-Induced Nonalcoholic Steatohepatitis by Improving Gut Microbiota To Attenuate Hepatic Injury and Regulate Metabolism. ACS Omega 2020; 5(33): 20800 doi: 10.1021/acsomega.0c01689
80
Hiroyuki Kitabatake, Naoki Tanaka, Naoyuki Fujimori, Michiharu Komatsu, Ayaka Okubo, Kyogo Kakegawa, Takefumi Kimura, Ayumi Sugiura, Tomoo Yamazaki, Soichiro Shibata, Yuki Ichikawa, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Masayoshi Koinuma, Kenji Sano, Toshifumi Aoyama, Eiji Tanaka. Association between endotoxemia and histological features of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(4): 712-722 doi: 10.3748/wjg.v23.i4.712
81
Sung-Min Won, Eunju Park, Jin-Ju Jeong, Raja Ganesan, Haripriya Gupta, Yoseph Gebru, SatyaPriya Sharma, Dong-Joon Kim, Ki-Tae Suk. The Gut Microbiota-Derived Immune Response in Chronic Liver Disease. International Journal of Molecular Sciences 2021; 22(15): 8309 doi: 10.3390/ijms22158309
82
Peter Christopher Konturek, Igor Alexander Harsch, Kathrin Konturek, Monic Schink, Thomas Konturek, Markus F. Neurath, Yurdaguel Zopf. Gut–Liver Axis: How Do Gut Bacteria Influence the Liver?. Medical Sciences 2018; 6(3): 79 doi: 10.3390/medsci6030079
83
Zhen-Shu Liu, Pei-Lin Li, Yu-We Ku, Po-Wen Chen. Oral Administration of Recombinant Lactoferrin-Expressing Probiotics Ameliorates Diet-Induced Lipid Accumulation and Inflammation in Non-Alcoholic Fatty Liver Disease in Mice. Microorganisms 2022; 10(11): 2215 doi: 10.3390/microorganisms10112215
84
M. J. Villanueva-Millán, P. Pérez-Matute, J. A. Oteo. Gut microbiota: a key player in health and disease. A review focused on obesity. Journal of Physiology and Biochemistry 2015; 71(3): 509 doi: 10.1007/s13105-015-0390-3
85
Yosep Ji, Young Mee Chung, Soyoung Park, Dahye Jeong, Bongjoon Kim, Wilhelm Heinrich Holzapfel. Dose-dependent and strain-dependent anti-obesity effects ofLactobacillus sakeiin a diet induced obese murine model. PeerJ 2019; 7: e6651 doi: 10.7717/peerj.6651
86
Jeonghyeon Kwon, Bobae Kim, Chungho Lee, Hyunchae Joung, Byoung-Kook Kim, In Suk Choi, Chang-Kee Hyun, Vanessa Souza-Mello. Comprehensive amelioration of high-fat diet-induced metabolic dysfunctions through activation of the PGC-1α pathway by probiotics treatment in mice. PLOS ONE 2020; 15(2): e0228932 doi: 10.1371/journal.pone.0228932
87
Dongqin Xu, Wenhao Zhao, Yiting Feng, Xiao Wen, Hanxiao Liu, Jie Ping. Pentoxifylline attenuates nonalcoholic fatty liver by inhibiting hepatic macrophage polarization to the M1 phenotype. Phytomedicine 2022; 106: 154368 doi: 10.1016/j.phymed.2022.154368
88
Mengjie Li, Zheng Zhang, Bin Yu, Siqiang Jia, Bo Cui. Lycium barbarum Oligosaccharides Alleviate Hepatic Steatosis by Modulating Gut Microbiota in C57BL/6J Mice Fed a High-Fat Diet. Foods 2023; 12(8): 1617 doi: 10.3390/foods12081617
89
Muhammad Nadeem Aslam, Christine M. Bassis, Li Zhang, Sameer Zaidi, James Varani, Ingrid L. Bergin, Valerio Pazienza. Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles. PLOS ONE 2016; 11(11): e0166178 doi: 10.1371/journal.pone.0166178
90
厚法 周. Research Progress of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease. Advances in Clinical Medicine 2022; 12(08): 7249 doi: 10.12677/ACM.2022.1281047
91
Lauren S. Strathearn, Afanasii I. Stepanov, Joan Font-Burgada. Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat Diets. Nutrients 2020; 12(4): 933 doi: 10.3390/nu12040933
92
Karen L. Chen, Zeynep Madak-Erdogan. Estrogens and female liver health. Steroids 2018; 133: 38 doi: 10.1016/j.steroids.2017.10.015
93
Tsai-Ching Hsu, Chih-Yang Huang, Chung-Hsien Liu, Kuo-Ching Hsu, Yi-Hsing Chen, Bor-Show Tzang. Lactobacillus paracasei GMNL-32, Lactobacillus reuteri GMNL-89 and L. reuteri GMNL-263 ameliorate hepatic injuries in lupus-prone mice. British Journal of Nutrition 2017; 117(8): 1066 doi: 10.1017/S0007114517001039
94
Weifeng Zhu, Ying Zhou, Rong Tsao, Huanhuan Dong, Hua Zhang. Amelioratory Effect of Resistant Starch on Non-alcoholic Fatty Liver Disease via the Gut-Liver Axis. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.861854
95
Hayley A. Braun, Sarah A. Faasse, Miriam B. Vos. Advances in Pediatric Fatty Liver Disease. Gastroenterology Clinics of North America 2018; 47(4): 949 doi: 10.1016/j.gtc.2018.07.016
96
Ying Zhao, Dong Zeng, Hesong Wang, Xiaodan Qing, Ning Sun, Jinge Xin, Min Luo, Abdul Khalique, Kangcheng Pan, Gang Shu, Bo Jing, Xueqin Ni. Dietary Probiotic Bacillus licheniformis H2 Enhanced Growth Performance, Morphology of Small Intestine and Liver, and Antioxidant Capacity of Broiler Chickens Against Clostridium perfringens–Induced Subclinical Necrotic Enteritis. Probiotics and Antimicrobial Proteins 2020; 12(3): 883 doi: 10.1007/s12602-019-09597-8
97
Gong-Jing Guo, Fei Yao, Wei-Peng Lu, Hao-Ming Xu. Gut microbiome and metabolic-associated fatty liver disease: Current status and potential applications. World Journal of Hepatology 2023; 15(7): 867-882 doi: 10.4254/wjh.v15.i7.867
98
Huicui Liu, Chenxi Nie, Xinzhong Hu, Juxiu Li. Highland barley β-glucan supplementation attenuated hepatic lipid accumulation in Western diet-induced non-alcoholic fatty liver disease mice by modulating gut microbiota. Food & Function 2024; 15(3): 1250 doi: 10.1039/D3FO03386D
99
Sujie Liu, Juan Wu, Pingping Chen, Shadi A. D. Mohammed, Jingbo Zhang, Shumin Liu, Syed Sameer Aga. TAK-242 Ameliorates Hepatic Fibrosis by Regulating the Liver-Gut Axis. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/4949148
100
Ji-Hee Shin, Yoonmi Lee, Eun-Ji Song, Dokyung Lee, Seo-Yul Jang, Hye Rim Byeon, Moon-Gi Hong, Sang-Nam Lee, Hyun-Jin Kim, Jae-Gu Seo, Dae Won Jun, Young-Do Nam. Faecalibacterium prausnitzii prevents hepatic damage in a mouse model of NASH induced by a high-fructose high-fat diet. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1123547
101
Nwe Ni Than, Philip N. Newsome. A concise review of non-alcoholic fatty liver disease. Atherosclerosis 2015; 239(1): 192 doi: 10.1016/j.atherosclerosis.2015.01.001
102
Benjamin Lelouvier, Florence Servant, Sandrine Païssé, Anne‐Claire Brunet, Salah Benyahya, Matteo Serino, Carine Valle, Maria Rosa Ortiz, Josep Puig, Michael Courtney, Massimo Federici, José‐Manuel Fernández‐Real, Rémy Burcelin, Jacques Amar. Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis. Hepatology 2016; 64(6): 2015 doi: 10.1002/hep.28829
103
S. V. Orlova, A. N. Vodolazkaya, O. I. Tarasova, E. A. Nikitina, E. V. Prokopenko, N. V. Balashova, I. S. Minosyan, V. V. Urazov. Phytonutrients in complex diet therapy for alcoholic liver disease and non-alcoholic fatty liver disease. Medical alphabet 2024; (16): 13 doi: 10.33667/2078-5631-2024-16-13-18
104
Yuzhen Zhao, Jianli Zhou, Jiaqi Liu, Zhaoxia Wang, Moxian Chen, Shaoming Zhou. Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease. Frontiers in Pediatrics 2019; 7 doi: 10.3389/fped.2019.00518
105
Erica Jennison, Christopher D. Byrne. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clinical and Molecular Hepatology 2021; 27(1): 22 doi: 10.3350/cmh.2020.0129
106
Francesca Marciano, Pietro Vajro. Gastrointestinal Tissue. 2017; : 113 doi: 10.1016/B978-0-12-805377-5.00008-4
107
Nageena Qayyum, Mohamedelfatieh Ismael, Han Haoyue, Honghui Guo, Xin Lü. Dietary supplementation of probiotic Lactobacillus modulates metabolic dysfunction‐associated steatotic liver disease and intestinal barrier integrity in obesity‐induced mice. Journal of Food Science 2024;  doi: 10.1111/1750-3841.17439
108
Jumana Abuqwider, Mohammad Altamimi, Gianluigi Mauriello. Limosilactobacillus reuteri in Health and Disease. Microorganisms 2022; 10(3): 522 doi: 10.3390/microorganisms10030522
109
Claudia Muscarà, Antonio Speciale, Maria Sofia Molonia, Federica Lina Salamone, Antonella Saija, Francesco Cimino. Intestinal epithelial differentiation and barrier function is promoted in vitro by a Cynara cardunculus L. leaf extract through AMPK pathway activation . Natural Product Research 2024; : 1 doi: 10.1080/14786419.2024.2384080
110
Leilei Yu, Yaqi Yu, Yue Xiao, Fengwei Tian, Arjan Narbad, Qixiao Zhai, Wei Chen. Lead-induced gut injuries and the dietary protective strategies: A review. Journal of Functional Foods 2021; 83: 104528 doi: 10.1016/j.jff.2021.104528
111
Zhu Ming, Xie Ruishi, Xu Linyi, Yang Yonggang, Luo Haoming, Lan Xintian. The gut-liver axis in fatty liver disease: role played by natural products. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1365294
112
Marica Meroni, Miriam Longo, Paola Dongiovanni. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. Nutrients 2019; 11(11): 2642 doi: 10.3390/nu11112642
113
Vahibe Uluçay Kestane, Murat Baş. Efficacy of the Mediterranean Diet Containing Different Macronutrients on Non-Alcoholic Fatty Liver Disease. Nutrients 2024; 16(16): 2699 doi: 10.3390/nu16162699
114
Lu-Lu Gao, Jia-Min Ma, Yan-Na Fan, Yan-Nan Zhang, Rui Ge, Xiu-Juan Tao, Meng-Wei Zhang, Qing-Han Gao, Jian-Jun Yang. Lycium barbarum polysaccharide combined with aerobic exercise ameliorated nonalcoholic fatty liver disease through restoring gut microbiota, intestinal barrier and inhibiting hepatic inflammation. International Journal of Biological Macromolecules 2021; 183: 1379 doi: 10.1016/j.ijbiomac.2021.05.066
115
Huw Purssell, Peter J Whorwell, Varinder S Athwal, Dipesh H Vasant. Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?. World Journal of Hepatology 2021; 13(12): 1816-1827 doi: 10.4254/wjh.v13.i12.1816
116
Mihaela Rotaru, Ana-Maria Singeap, Alin Ciobica, Laura Huiban, Carol Stanciu, Laura Romila, Vasile Burlui, Ioannis Mavroudis, Anca Trifan. Oral Health and “Modern” Digestive Diseases: Pathophysiologic and Etiologic Factors. Biomedicines 2024; 12(8): 1854 doi: 10.3390/biomedicines12081854
117
Alejandra Altamirano-Barrera, Misael Uribe, Norberto C. Chávez-Tapia, Natalia Nuño-Lámbarri. The role of the gut microbiota in the pathology and prevention of liver disease. The Journal of Nutritional Biochemistry 2018; 60: 1 doi: 10.1016/j.jnutbio.2018.03.006
118
Oliwia Gawlik-Kotelnicka, Jacek Burzyński, Jakub Rogalski, Anna Skowrońska, Dominik Strzelecki. Probiotics may be useful for drug-induced liver dysfunction in patients with depression – A secondary analysis of a randomized clinical trial. Clinical Nutrition ESPEN 2024; 63: 604 doi: 10.1016/j.clnesp.2024.07.1024
119
Eric K. Kwong, Huiping Zhou. Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases. Liver Research 2019; 3(1): 19 doi: 10.1016/j.livres.2019.02.003
120
Zeinab El Rashed, Elena Grasselli, Hala Khalifeh, Laura Canesi, Ilaria Demori. Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease. Planta Medica 2022; 88(01): 9 doi: 10.1055/a-1273-3159
121
Xin Dai, Bangmao Wang. Role of Gut Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/287348
122
Hirofumi Okubo, Akifumi Kushiyama, Yusuke Nakatsu, Takeshi Yamamotoya, Yasuka Matsunaga, Midori Fujishiro, Hideyuki Sakoda, Haruya Ohno, Masayasu Yoneda, Tomoichiro Asano. Roles of Gut-Derived Secretory Factors in the Pathogenesis of Non-Alcoholic Fatty Liver Disease and Their Possible Clinical Applications. International Journal of Molecular Sciences 2018; 19(10): 3064 doi: 10.3390/ijms19103064
123
Natalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, Dimitrios Tsilingiris, Faidon Magkos, Theodora Stratigou, Dimitris Kounatidis, Maria Dalamaga. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2021; 12(1): 56 doi: 10.3390/biom12010056
124
Yunfei Luo, Hui Lin. Inflammation initiates a vicious cycle between obesity and nonalcoholic fatty liver disease. Immunity, Inflammation and Disease 2021; 9(1): 59 doi: 10.1002/iid3.391
125
Saba Mohammadi, Fatemeh Rostamkhani, Shahin Riyahi Malayeri, Hossein Shirvani. High-intensity interval training with probiotic supplementation decreases gene expression of NF-κβ and CXCL2 in small intestine of rats with steatosis. Sport Sciences for Health 2022; 18(2): 491 doi: 10.1007/s11332-021-00829-5
126
Marco Poeta, Luca Pierri, Pietro Vajro. Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease. Children 2017; 4(8): 66 doi: 10.3390/children4080066
127
Jun Zhang, Jing Zhou, Zheyun He, Hongshan Li. Bacteroides and NAFLD: pathophysiology and therapy. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1288856
128
Yun Li, Tianyu Liu, Chen Yan, Runxiang Xie, Zixuan Guo, Sinan Wang, Yujie Zhang, Zhengxiang Li, Bangmao Wang, Hailong Cao. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier. Molecular Pharmaceutics 2018; 15(9): 3860 doi: 10.1021/acs.molpharmaceut.8b00347
129
Xiaofei Pan, Tao Ma, Peng Li, Xin Jiang, Shuang Song, Max Q.-H. Meng. A novel intestinal microcapsule endoscope robot with biopsy function. 2018 IEEE International Conference on Cyborg and Bionic Systems (CBS) 2018; : 308 doi: 10.1109/CBS.2018.8612210
130
Elisabeth Govers. Obesity and Insulin Resistance Are the Central Issues in Prevention of and Care for Comorbidities. Healthcare 2015; 3(2): 408 doi: 10.3390/healthcare3020408
131
Kattayoun Kordy, Fan Li, David J. Lee, Jason M. Kinchen, Michael H. Jew, Maria Eduarda La Rocque, Sofia Martinez, Sara Zabih, Monica Saavedra, Cora Woodward, Nicole J. Cunningham, Nicole H. Tobin, Grace M. Aldrovandi. Multi-Omic Predictors of Steatohepatitis and Advanced Fibrosis in Children. SSRN Electronic Journal 2018;  doi: 10.2139/ssrn.3299431
132
Vishal C. Patel, Roger Williams. Antimicrobial resistance in chronic liver disease. Hepatology International 2020; 14(1): 24 doi: 10.1007/s12072-019-10004-1
133
Ashwin Rajeev, Aiswarya Sudheer, Indranil Chattopadhyay. Probiotics as a Sustainable Approach in Health Enrichment. Journal of Pure and Applied Microbiology 2024; 18(1): 80 doi: 10.22207/JPAM.18.1.02
134
G.T. Cao, B. Dai, K.L. Wang, Y. Yan, Y.L. Xu, Y.X. Wang, C.M. Yang. Bacillus licheniformis , a potential probiotic, inhibits obesity by modulating colonic microflora in C57BL/6J mice model . Journal of Applied Microbiology 2019; 127(3): 880 doi: 10.1111/jam.14352
135
Yaochuan Zhou, Dandan Zhang, Hao Cheng, Jinlu Wu, Juan Liu, Wuwen Feng, Cheng Peng. Repairing gut barrier by traditional Chinese medicine: roles of gut microbiota. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1389925
136
Elvira Verduci, Carlotta Lassandro, Giovanni Radaelli, Laura Soldati. Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach?. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0471-7
137
Lu-Lu Gao, Yu-Xiang Li, Jia-Min Ma, Yi-Qiong Guo, Lin Li, Qing-Han Gao, Yan-Na Fan, Meng-Wei Zhang, Xiu-Juan Tao, Jian-Qiang Yu, Jian-Jun Yang. Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial. Trials 2021; 22(1) doi: 10.1186/s13063-021-05529-6
138
Ahyoung Kim, Arunkumar Krishnan, James P. Hamilton, Tinsay A. Woreta. The Impact of Dietary Patterns and Nutrition in Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2021; 50(1): 217 doi: 10.1016/j.gtc.2020.10.013
139
Minmin Luo, Junbin Yan, Liyan Wu, Jinting Wu, Zheng Chen, Jianping Jiang, Zhiyun Chen, Beihui He, Fabiano Carvalho. Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway. Journal of Immunology Research 2021; 2021: 1 doi: 10.1155/2021/2264737
140
Li Wang, Zheng-Min Cao, Li-Li Zhang, Juan-mei Li, Wen-liang Lv. The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.923599
141
Siming Yang, Zhiguang Duan, Sen Zhang, Cuiying Fan, Chenhui Zhu, Rongzhan Fu, Xiaoxuan Ma, Daidi Fan. Ginsenoside Rh4 Improves Hepatic Lipid Metabolism and Inflammation in a Model of NAFLD by Targeting the Gut Liver Axis and Modulating the FXR Signaling Pathway. Foods 2023; 12(13): 2492 doi: 10.3390/foods12132492
142
Wesam Bahitham, Siraj Alghamdi, Ibrahim Omer, Ali Alsudais, Ilana Hakeem, Arwa Alghamdi, Reema Abualnaja, Faisal M. Sanai, Alexandre S. Rosado, Consolato M. Sergi. Double Trouble: How Microbiome Dysbiosis and Mitochondrial Dysfunction Drive Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis. Biomedicines 2024; 12(3): 550 doi: 10.3390/biomedicines12030550
143
Ivana Mikolasevic, Lidija Orlic, Neven Franjic, Goran Hauser, Davor Stimac, Sandra Milic. Transient elastography (FibroScan<sup>&reg;</sup>) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?. World Journal of Gastroenterology 2016; 22(32): 7236-7251 doi: 10.3748/wjg.v22.i32.7236
144
Xiaoli Zhang, Yunpeng Dong, Guoying Sun, Ahmed A. Hasan, Mei Tian, Suimin Zeng, Jing Li, Shiyu Zeng, Jun Ma, Jian Li, Berthold Hocher. Paternal Programming of Liver Function and Lipid Profile Induced by a Paternal Pre-Conceptional Unhealthy Diet: Potential Association with Altered Gut Microbiome Composition. Kidney and Blood Pressure Research 2019; 44(1): 133 doi: 10.1159/000497487
145
Breann E Abernathy, Tonya C Schoenfuss, Allison S Bailey, Daniel D Gallaher. Polylactose Exhibits Prebiotic Activity and Reduces Adiposity and Nonalcoholic Fatty Liver Disease in Rats Fed a High-Fat Diet. The Journal of Nutrition 2021; 151(2): 352 doi: 10.1093/jn/nxaa376
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345